Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Rangering i aksjer #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Aksjekurs
$0.14942078
Sist synkronisert: 2025-05-15
Markedsverdi
$3.86M
Endring (1 dag)
0.10%
Endring (1 år)
0.00%
Land
DE
Handel Medigene AG (MDG1)

Kategori

Inntekter for Medigene AG (MDG1)
Inntekter i Jun 2024 TTM: $7.99M
Ifølge de nyeste økonomiske rapportene til Medigene AG er selskapets nåværende inntekter (TTM) $7.99M. I 2022 hadde selskapet inntekter på $33.52M en økning sammenlignet med inntektene i 2021, som var $11.90M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Medigene AG fra 2004 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $7.99M 19.85%
2023 $6.67M -80.10%
2022 $33.52M 181.71%
2021 $11.90M 22.09%
2020 $9.75M -17.36%
2019 $11.79M 35.46%
2018 $8.71M -5.48%
2017 $9.21M 113.45%
2016 $4.32M 28.15%
2015 $3.37M -77.88%
2014 $15.22M 46.65%
2013 $10.38M 34.07%
2012 $7.74M 160.02%
2011 $2.98M 0.59%
2010 $2.96M -94.55%
2009 $54.28M 16.25%
2008 $46.70M 44.83%
2007 $32.24M -19.79%
2006 $40.20M 73.97%
2005 $23.11M 36.31%
2004 $16.95M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$12.62B 157,814.80%
US
$6.02B 75,219.06%
NL
- -
CH
- -
KR
$10.11B 126,373.78%
BE